Ovarian Cancer and Us - best viewed in FIREFOX

Search: this blog, links from posts and the web.....

Loading...

Sunday, December 21, 2008

Relapse and survival in early-stage ovarian cancer



Relapse and survival in early-stage ovarian cancer. [Arch Gynecol Obstet. 2008] - PubMed Result

CONCLUSION:

Patients with early ovarian cancer stage pT1c and pT2a or low grade tumor have to be

monitored closely in oncologic follow-up as they bare a significant risk for disease recurrence.

Ascites at primary diagnosis, pT1c or pT2a tumor stage or recurrent disease are associated

with a poor survival even in
early ovarian cancer.

Relationship between hormone therapy in women with ovarian malignancy and prognosis



[Relationship between hormone therapy in women wit...[Zhonghua Fu Chan Ke Za Zhi. 2008] - PubMed Result

Patient satisfaction with quality of life as a prognostic indicator in ovarian cancer patients treated in an integrative treatment setting



Patient satisfaction with quality of life as a pro...[J Soc Integr Oncol. 2008] - PubMed Result

"Our study has demonstrated no statistically significant prognostic association of patient satisfaction with QoL, as measured by the QLI, with survival in ovarian cancer."

Abstract/full free text: Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.



Abstract | Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome.

Population-based detection of Lynch syndrome in young colorectal cancer patients using microsatellite instability as the initial test.



Population-based detection of Lynch syndrome in yo...[Int J Cancer. 2008] - PubMed Result

eMJA: Doctor displacement: a political agenda or a health care imperative?



eMJA: Doctor displacement: a political agenda or a health care imperative?

Canadian Doctors for Medicare-Position on Activity-based funding in Canadian Hospitals and other Surgical Facilities (references intl sources)



ABF-final-9.8.8.pdf (application/pdf Object)

What is activity-based funding?

Widespread confusion exists around the jargon used to describe different ways of funding
hospitals.

Activity-based funding (ABF) is also known in the UK as payment-by-results

(PbR), as patient-focused funding (PFF) by the Canadian Medical Association, as servicebased
funding or case-mix funding by the Kirby Commission, as prospective payment
system (PPS) in the US, and elsewhere as payment-for-volume, or volume-based funding.

We use the relatively neutral term of activity-based funding, because the focus is not
necessarily on the patient, but rather on the type and volume of service delivered.

Health and QOL Outcomes: How do medical students value health - evaluation of hypothetical health states compared to the general population



1477-7525-6-111.pdf (application/pdf Object)

In a recent European survey on the acceptance of quality of life measurement between 72-90% of
the physicians accepted quality of life (QoL) as an outcome measure, however with less than 50%
accepting the concept of quality adjusted life years (including utility measurement) [2]. In a similar
survey in the United States and Canada only about one third of the physicians had ever collected
data on quality of life or had taken it systematically into account in clinical decision making [3].
Medical students gain a different perspective on health problems during their medical education by developing the role of a medical doctor. The participation in a health state
valuation task potentially allows them to reflect on a patients’ perspective on decision making when
being confronted with hypothetical health states. Further it has been acknowledged that there is a
need for health related quality of life education in medical school [4]......Futures studies should investigate the change of health states valuations of health care professionals over the period of their medical training.

Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw



Canadian consensus practice guidelines for bisphos...[J Rheumatol. 2008] - PubMed Result

SABCS: Breast Cancer Risk No Higher for BRCA1/2-Negative Women from Mutation-Positive Families - Meeting Coverage



Medical News: SABCS: Breast Cancer Risk No Higher for BRCA1/2-Negative Women from Mutation-Positive Families - in Meeting Coverage, SABCS from MedPage Today


Action Points

* Explain to patients that women who are not carriers of BRCA1/2 mutations do not have an increased risk of breast cancer, even if they come from a mutation-positive family.

* Note that this study was published as an abstract and presented orally at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.

Management of complications from estrogen deprivation in breast cancer patients



SpringerLink - Journal Article